Dissecting the Association Between Inflammation, Metabolic Dysregulation, and Specific Depressive Symptoms

JAMA Psychiatry - Tập 78 Số 2 - Trang 161 - 2021
Nils Kappelmann1,2, Janine Arloth1,3, Marios K. Georgakis4, Darina Czamara1, Nicolas Rost1,2, Symen Ligthart5, Golam M. Khandaker6,7, Elisabeth B. Binder1
1Department of Research in Translational Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany
2International Max Planck Research School for Translational Psychiatry, Munich, Germany
3Institute of Computational Biology, Helmholtz Zentrum Munich, Neuherberg, Germany
4Institute for Stroke and Dementia Research, University Hospital, Ludwig Maximilians University, Munich, Germany
5Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands
6Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, United Kingdom
7Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom

Tóm tắt

Từ khóa


Tài liệu tham khảo

Dantzer, 2008, From inflammation to sickness and depression: when the immune system subjugates the brain., Nat Rev Neurosci, 9, 46, 10.1038/nrn2297

Khandaker, 2014, Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study., JAMA Psychiatry, 71, 1121, 10.1001/jamapsychiatry.2014.1332

Osimo, 2019, Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels., Psychol Med, 49, 1958, 10.1017/S0033291719001454

Lamers, 2018, Metabolic and inflammatory markers: associations with individual depressive symptoms., Psychol Med, 48, 1102, 10.1017/S0033291717002483

Jokela, 2016, Inflammation and specific symptoms of depression., JAMA Psychiatry, 73, 87, 10.1001/jamapsychiatry.2015.1977

Fried, Using network analysis to examine links between individual depressive symptoms, inflammatory markers, and covariates., Psychol Med

Chu, 2019, Longitudinal association between inflammatory markers and specific symptoms of depression in a prospective birth cohort., Brain Behav Immun, 76, 74, 10.1016/j.bbi.2018.11.007

Moriarity, 2019, Inflammatory proteins predict change in depressive symptoms in male and female adolescents., Clin Psychol Sci, 7, 754, 10.1177/2167702619826586

Duivis, 2013, Differential association of somatic and cognitive symptoms of depression and anxiety with inflammation: findings from the Netherlands Study of Depression and Anxiety (NESDA)., Psychoneuroendocrinology, 38, 1573, 10.1016/j.psyneuen.2013.01.002

Milaneschi, 2020, Depression heterogeneity and its biological underpinnings: toward immunometabolic depression., Biol Psychiatry, 88, 369, 10.1016/j.biopsych.2020.01.014

Wittenberg, 2020, Effects of immunomodulatory drugs on depressive symptoms: a mega-analysis of randomized, placebo-controlled clinical trials in inflammatory disorders., Mol Psychiatry, 25, 1275, 10.1038/s41380-019-0471-8

Kappelmann, 2018, Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions., Mol Psychiatry, 23, 335, 10.1038/mp.2016.167

Köhler, 2014, Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials., JAMA Psychiatry, 71, 1381, 10.1001/jamapsychiatry.2014.1611

Köhler-Forsberg, 2019, Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: meta-analysis of clinical trials., Acta Psychiatr Scand, 139, 404, 10.1111/acps.2019.139.issue-5

Raison, 2013, A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers., JAMA Psychiatry, 70, 31, 10.1001/2013.jamapsychiatry.4

McIntyre, 2019, Efficacy of adjunctive infliximab vs placebo in the treatment of adults with bipolar I/II depression: a randomized clinical trial., JAMA Psychiatry, 76, 783, 10.1001/jamapsychiatry.2019.0779

Khandaker, 2018, Protocol for the INSIGHT study: a randomised controlled trial of single-dose tocilizumab in patients with depression and low-grade inflammation., BMJ Open, 8, 10.1136/bmjopen-2018-025333

Howard, 2019, Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions., Nat Neurosci, 22, 343, 10.1038/s41593-018-0326-7

Ligthart, 2018, Genome analyses of >200,000 individuals identify 58 loci for chronic inflammation and highlight pathways that link inflammation and complex disorders., Am J Hum Genet, 103, 691, 10.1016/j.ajhg.2018.09.009

Martin, 2019, Predicting polygenic risk of psychiatric disorders., Biol Psychiatry, 86, 97, 10.1016/j.biopsych.2018.12.015

Milaneschi, 2017, Genetic association of major depression with atypical features and obesity-related immunometabolic dysregulations., JAMA Psychiatry, 74, 1214, 10.1001/jamapsychiatry.2017.3016

Milaneschi, 2016, Polygenic dissection of major depression clinical heterogeneity., Mol Psychiatry, 21, 516, 10.1038/mp.2015.86

Bulik-Sullivan, 2015, LD Score regression distinguishes confounding from polygenicity in genome-wide association studies., Nat Genet, 47, 291, 10.1038/ng.3211

Bulik-Sullivan, 2015, An atlas of genetic correlations across human diseases and traits., Nat Genet, 47, 1236, 10.1038/ng.3406

Smith, 2003, “Mendelian randomization”: can genetic epidemiology contribute to understanding environmental determinants of disease?, Int J Epidemiol, 32, 1, 10.1093/ije/dyg070

Davey Smith, 2005, What can mendelian randomisation tell us about modifiable behavioural and environmental exposures?, BMJ, 330, 1076, 10.1136/bmj.330.7499.1076

Hingorani, 2005, Nature’s randomised trials., Lancet, 366, 1906, 10.1016/S0140-6736(05)67767-7

Wium-Andersen, 2014, Elevated C-reactive protein, depression, somatic diseases, and all-cause mortality: a mendelian randomization study., Biol Psychiatry, 76, 249, 10.1016/j.biopsych.2013.10.009

Khandaker, 2020, Shared mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort., Mol Psychiatry, 25, 1477, 10.1038/s41380-019-0395-3

Wray, 2018, Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression., Nat Genet, 50, 668, 10.1038/s41588-018-0090-3

Locke, 2015, Genetic studies of body mass index yield new insights for obesity biology., Nature, 518, 197, 10.1038/nature14177

Wood, 2014, Defining the role of common variation in the genomic and biological architecture of adult human height., Nat Genet, 46, 1173, 10.1038/ng.3097

Sun, 2018, Genomic atlas of the human plasma proteome., Nature, 558, 73, 10.1038/s41586-018-0175-2

Jansen, 2019, Genome-wide analysis of insomnia in 1,331,010 individuals identifies new risk loci and functional pathways., Nat Genet, 51, 394, 10.1038/s41588-018-0333-3

Rosa, 2019, A Mendelian randomization study of IL6 signaling in cardiovascular diseases, immune-related disorders and longevity., NPJ Genom Med, 4, 23, 10.1038/s41525-019-0097-4

Lam, 2020, RICOPILI: Rapid Imputation for COnsortias PIpeLIne., Bioinformatics, 36, 930, 10.1093/bioinformatics/btz633

Löwe, 2004, Monitoring depression treatment outcomes with the Patient Health Questionnaire-9., Med Care, 42, 1194, 10.1097/00005650-200412000-00006

Davis, 2020, Mental health in UK Biobank: development, implementation and results from an online questionnaire completed by 157 366 participants: a reanalysis., BJPsych Open, 6, 10.1192/bjo.2019.100

Murray, 1994, A comprehensive human linkage map with centimorgan density., Science, 265, 2049, 10.1126/science.8091227

Auton, 2015, A global reference for human genetic variation., Nature, 526, 68, 10.1038/nature15393

Benjamini, 1995, Controlling the false discovery rate: a practical and powerful approach to multiple testing., J R Stat Soc Series B Stat Methodol, 57, 289, 10.1111/j.2517-6161.1995.tb02031.x

Hunter, 2015, IL-6 as a keystone cytokine in health and disease., Nat Immunol, 16, 448, 10.1038/ni.3153

Del Giudice, 2018, Rethinking IL-6 and CRP: why they are more than inflammatory biomarkers, and why it matters., Brain Behav Immun, 70, 61, 10.1016/j.bbi.2018.02.013

Ridker, 2016, From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection., Circ Res, 118, 145, 10.1161/CIRCRESAHA.115.306656

Calabrese, 2014, IL-6 biology: implications for clinical targeting in rheumatic disease., Nat Rev Rheumatol, 10, 720, 10.1038/nrrheum.2014.127

Palmer, 2012, Using multiple genetic variants as instrumental variables for modifiable risk factors., Stat Methods Med Res, 21, 223, 10.1177/0962280210394459

Georgakis, 2020, Interleukin-6 signaling effects on ischemic stroke and other cardiovascular outcomes: a Mendelian randomization study., Circ Genom Precis Med, 13, 10.1161/CIRCGEN.119.002872

Pierce, 2011, Power and instrument strength requirements for Mendelian Randomization studies using multiple genetic variants., Int J Epidemiol, 40, 740, 10.1093/ije/dyq151

Hartwig, 2016, Body mass index and psychiatric disorders: a Mendelian randomization study., Sci Rep, 6, 32730, 10.1038/srep32730

Hemani, 2018, The MR-Base platform supports systematic causal inference across the human phenome., eLife, 7, 1, 10.7554/eLife.34408

Hemani, 2018, Evaluating the potential role of pleiotropy in Mendelian randomization studies., Hum Mol Genet, 27, R195, 10.1093/hmg/ddy163

Lawlor, 2008, Mendelian randomization: using genes as instruments for making causal inferences in epidemiology., Stat Med, 27, 1133, 10.1002/(ISSN)1097-0258

Burgess, 2017, A review of instrumental variable estimators for Mendelian randomization., Stat Methods Med Res, 26, 2333, 10.1177/0962280215597579

Bowden, 2016, Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator., Genet Epidemiol, 40, 304, 10.1002/gepi.2016.40.issue-4

Greco M, 2015, Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome., Stat Med, 34, 2926, 10.1002/sim.v34.21

Burgess, 2017, Interpreting findings from Mendelian randomization using the MR-Egger method., Eur J Epidemiol, 32, 377, 10.1007/s10654-017-0255-x

Bowden, 2015, Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression., Int J Epidemiol, 44, 512, 10.1093/ije/dyv080

Turecki, 2016, Suicide and suicidal behaviour., Lancet, 387, 1227, 10.1016/S0140-6736(15)00234-2

Turecki, 2014, The molecular bases of the suicidal brain., Nat Rev Neurosci, 15, 802, 10.1038/nrn3839

Black, 2015, Meta-analysis of cytokines and chemokines in suicidality: distinguishing suicidal versus nonsuicidal patients., Biol Psychiatry, 78, 28, 10.1016/j.biopsych.2014.10.014

Ganança, 2016, The role of cytokines in the pathophysiology of suicidal behavior., Psychoneuroendocrinology, 63, 296, 10.1016/j.psyneuen.2015.10.008

Brundin, 2015, The role of inflammation in suicidal behaviour., Acta Psychiatr Scand, 132, 192, 10.1111/acps.2015.132.issue-3

Gradus, 2010, Inflammatory bowel disease and completed suicide in Danish adults., Inflamm Bowel Dis, 16, 2158, 10.1002/ibd.21298

Milaneschi, 2017, Leptin dysregulation is specifically associated with major depression with atypical features: evidence for a mechanism connecting obesity and depression., Biol Psychiatry, 81, 807, 10.1016/j.biopsych.2015.10.023

Lamers, 2020, Depression profilers and immuno-metabolic dysregulation: longitudinal results from the NESDA study., Brain Behav Immun, 88, 174, 10.1016/j.bbi.2020.04.002

Simmons, 2020, Appetite changes reveal depression subgroups with distinct endocrine, metabolic, and immune states., Mol Psychiatry, 25, 1457, 10.1038/s41380-018-0093-6

Fedewa, 2017, Effect of exercise training on C reactive protein: a systematic review and meta-analysis of randomised and non-randomised controlled trials., Br J Sports Med, 51, 670, 10.1136/bjsports-2016-095999

Bauer, 2019, Inflammation in psychiatric disorders: what comes first?, Ann N Y Acad Sci, 1437, 57, 10.1111/nyas.2019.1437.issue-1

Flett, 1997, The continuity of depression in clinical and nonclinical samples., Psychol Bull, 121, 395, 10.1037/0033-2909.121.3.395

Haycock, 2016, Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies., Am J Clin Nutr, 103, 965, 10.3945/ajcn.115.118216

Ohlsson, Applying causal inference methods in psychiatric epidemiology: a review., JAMA Psychiatry

American Psychiatric Association, 1994, Diagnostic and Statistical Manual of Mental Disorders, 4th ed

An efficacy and safety study of sirukumab in participants with major depressive disorder. ClinicalTrials.gov identifier: NCT02473289. Updated June 11, 2019. Accessed September 14, 2020. https://clinicaltrials.gov/ct2/show/NCT02473289

Biomarkers of neuroinflammation and anti-inflammatory treatments in major depressive disorder. ClinicalTrials.gov identifier: NCT02362529. Updated May 23, 2019. Accessed September 14, 2020. https://clinicaltrials.gov/ct2/show/NCT02362529

Neale Lab UK Biobank. Accessed September 14, 2020. https://www.nealelab.is/uk-biobank/

R Core Team. R: The R Project for Statistical Computing. Accessed September 14, 2020. https://www.r-project.org/

Open Science Framework. Dissecting the association between inflammation, metabolic dysregulation, and specific depressive symptoms. Last updated August 21, 2020. Accessed September 14, 2020. https://osf.io/ub83a/